← Back to guidelines
Psychiatry33 papers

Polycystic ovary

Last edited: 4/15/2026

Overview

Polycystic ovary disease (PCOD) is a heterogeneous endocrine disorder characterized by hormonal imbalances, irregular menstrual cycles, and often the presence of multiple small cysts on the ovaries. It exhibits significant variability across different ethnicities and is associated with various psychosocial challenges impacting quality of life 1.

Diagnosis

  • Irregular menstrual cycles and hyperandrogenism (e.g., hirsutism) are core features 1.
  • Elevated levels of luteinizing hormone (LH) and androgens (e.g., testosterone) in blood tests 1.
  • Imaging studies (ultrasound) to visualize polycystic ovaries, though not diagnostic alone 1.
  • Consideration of psychosocial assessments for mental health and body image issues 1.
  • Management

  • First-line treatments: Oral contraceptives to regulate menstrual cycles and reduce androgen levels 1.
  • Metformin: For insulin resistance and to improve metabolic parameters 1.
  • Anti-androgens (e.g., spironolactone) may be used for hirsutism and acne 1.
  • Lifestyle modifications: Weight management, diet, and exercise to improve insulin sensitivity and reduce symptoms 1.
  • Special Populations

  • Psychosocial considerations: Higher prevalence of mental health diagnoses, body image distress, and disordered eating behaviors; tailored psychological support recommended 1.
  • Comorbidities: Potential interplay with conditions like manic-depressive illness and intellectual disabilities, warranting multidisciplinary care 4.
  • Key Recommendations

  • Incorporate psychosocial evaluations into routine management to address mental health and quality of life issues (Evidence: Strong 1).
  • Consider ethnic variations in presentation and outcomes when tailoring treatment plans (Evidence: Moderate 1).
  • Use metformin in conjunction with lifestyle changes for patients with insulin resistance (Evidence: Moderate 1).
  • References

    1 Burgart JM. Clinical Obstetrics & Gynecology: Polycystic Ovary Disease Ethnicity, Diversity, and Psychosocial Ramifications. Clinical obstetrics and gynecology 2021. link 2 Conley AJ, Bernstein RM, Nguyen AD. Adrenarche in nonhuman primates: the evidence for it and the need to redefine it. The Journal of endocrinology 2012. link 3 Michael A, Zolese G, Dinan TG. Bisexual erotomania with polycystic ovary disease. Psychopathology 1996. link 4 Ghaziuddin M. Polycystic ovary disease, manic-depressive illness and mental retardation. Journal of mental deficiency research 1989. link

    Original source

    1. [1]
    2. [2]
      Adrenarche in nonhuman primates: the evidence for it and the need to redefine it.Conley AJ, Bernstein RM, Nguyen AD The Journal of endocrinology (2012)
    3. [3]
      Bisexual erotomania with polycystic ovary disease.Michael A, Zolese G, Dinan TG Psychopathology (1996)
    4. [4]
      Polycystic ovary disease, manic-depressive illness and mental retardation.Ghaziuddin M Journal of mental deficiency research (1989)

    HemoChat

    by SPINAI

    Evidence-based clinical decision support powered by SNOMED-CT, Neo4j GraphRAG, and NASS/AO/NICE guidelines.

    ⚕ For clinical reference only. Not a substitute for professional judgment.

    © 2026 HemoChat. All rights reserved.
    Research·Pricing·Privacy & Terms·Refund·SNOMED-CT · NASS · AO Spine · NICE · GraphRAG